J-Pharma Co.,Ltd.

520A TSE Pharmaceuticals Pharmaceutical
TSE Growth

Shareholding pattern

As reported in the annual securities report, 2026-03-31.

Foreign institutions23.22%
Individuals55.32%
Top 10 holders49.69%
Total shareholders9,738

Who owns the company

Share of voting units
Individuals & others: 55.32%Foreign institutions: 23.22%Other corporations: 17.04%Securities firms: 2.63%Financial institutions: 1.58%Foreign individuals: 0.21%55.3%Individuals & others
Individuals & others 55.32%Foreign institutions 23.22%Other corporations 17.04%Securities firms 2.63%Financial institutions 1.58%Foreign individuals 0.21%

How to read this: each slice is a group of investors. Foreign and financial institutions are professional money; individuals are retail shareholders; other corporations are usually business partners holding strategic stakes. A large institutional slice generally means heavier analyst coverage and more trading volume.

Ownership detail

Investor categoryHolding %Shareholders
Individuals & others55.32%9,536
Foreign institutions23.22%20
Other corporations17.04%80
Securities firms2.63%16
Financial institutions1.58%5
Foreign individuals0.21%81

How to read this: a high foreign or institutional share often means the stock is widely researched and more liquid; a high individual share means retail investors hold most of the company. Percentages are of voting units.

Largest shareholders

S.No.ShareholderSharesStake %
1JICベンチャー・グロース・ファンド1号投資事業有限責任組合1,859,32510.34%
2EIGHT ROADS VENTURES JAPAN II LP(常任代理人 Eight Roads・キャピタル・アドバイザーズ・ホンコン・リミテッド)1,616,0008.99%
3NEWTON BIOCAPITAL I SA. PRICAF PRIVEE DE DROIT BELGE(常任代理人 三田証券株式会社)1,225,0006.81%
4大原薬品工業株式会社875,0004.87%
5UntroD 野村クロスオーバーインパクトファンド投資事業有限責任組合827,2004.60%
6スペラファーマ株式会社625,0003.48%
7MSIVCグローバルアカデミックシーズ投資事業有限責任組合527,5002.93%
8F-PRIME CAPITAL PARTNERS LIFE SCIENCES FUND VI LP(常任代理人 肥沼 誠)485,0002.70%
9OUVC1号投資事業有限責任組合462,5002.57%
10株式会社SBI証券432,2002.40%

Trust banks such as Master Trust and Custody Bank appear at the top of most Japanese registers: they hold shares on behalf of many underlying funds rather than owning them outright.

Educational data only. Not a recommendation to buy, sell or hold any security.